Journal of Dental Anesthesia and Pain Medicine

  • 제16권1호
  • /
  • Pages.67-71
  • /
  • 2016
  • /
  • 2383-9309(pISSN)
  • /
  • 2383-9317(eISSN)
대한치과마취과학회 (The Korean Dental Society of Anesthsiology)
권호 표지
DOI QR코드

DOI QR Code

Deep sedation for dental treatment in a Down syndrome patient with Eisenmenger syndrome: A case report

  • Chi, Seong In (Department of Dental Anesthesiology, School of Dentistry, Seoul National University) ;
  • Kim, Hyun Jeong (Department of Dental Anesthesiology, School of Dentistry, Seoul National University) ;
  • Seo, Kwang-Suk (Department of Dental Anesthesiology, School of Dentistry, Seoul National University)
  • 투고 : 2016.03.10
  • 심사 : 2016.03.28
  • 발행 : 2016.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Eisenmenger syndrome (ES) is characterized by pulmonary arterial hypertension and right-to-left shunting. The signs and symptoms of ES include cyanosis, shortness of breath, fatigue, hemoptysis, and sudden death. In patients with ES, it is important that the systemic and pulmonary circulations be properly distributed and maintained. General dental treatment is not known to be particularly dangerous. To control pain and anxiety, local anesthetics without epinephrine are usually recommended. However, in cases of difficulty of cooperation, general anesthesia for dental treatment makes the condition worse. In the present case, intravenous deep sedation with propofol and remifentanil was administered for behavioral management during dental treatment successfully.

키워드

참고문헌

  1. Hopkins WE. Severe pulmonary hypertension in congenital heart disease: A review of eisenmenger syndrome. Curr Opin Cardiol 1995; 10: 517-23. https://doi.org/10.1097/00001573-199509000-00013
  2. Raines DE, Liberthson RR, Murray JR. Anesthetic management and outcome following noncardiac surgery in nonparturients with eisenmenger's physiology. J Clin Anesth 1996; 8: 341-7. https://doi.org/10.1016/0952-8180(96)00084-0
  3. Kunimatsu T, Greenan S, Yamashita A, Yamamoto T, Ikeda M. Use of moderate sedation for a patient with down syndrome, intellectual disability, and eisenmenger syndrome: A case report. Spec Care Dentist 2011; 31: 41-3. https://doi.org/10.1111/j.1754-4505.2010.00171.x
  4. Pastore E, Marino B, Calzolari A, Digilio MC, Giannotti A, Turchetta A. Clinical and cardiorespiratory assessment in children with down syndrome without congenital heart disease. Arch Pediatr Adolesc Med 2000; 154: 408-10. https://doi.org/10.1001/archpedi.154.4.408
  5. Oechslin E, Mebus S, Schulze-Neick I, Niwa K, Trindade PT, Eicken A, et al. The adult patient with eisenmenger syndrome: A medical update after dana point part iii: Specific management and surgical aspects. Curr Cardiol Rev 2010; 6: 363-72. https://doi.org/10.2174/157340310793566127
  6. Somerville J. How to manage the eisenmenger syndrome. Int J Cardiol 1998; 63: 1-8. https://doi.org/10.1016/S0167-5273(97)00264-7
  7. Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998; 19: 1845-55. https://doi.org/10.1053/euhj.1998.1046
  8. Bennett JM, Ehrenfeld JM, Markham L, Eagle SS. Anesthetic management and outcomes for patients with pulmonary hypertension and intracardiac shunts and eisenmenger syndrome: A review of institutional experience. J Clin Anesth 2014; 26: 286-93. https://doi.org/10.1016/j.jclinane.2013.11.022
  9. Galie N, Manes A, Palazzini M, Negro L, Marinelli A, Gambetti S, et al. Management of pulmonary arterial hypertension associated with congenital systemic-topulmonary shunts and eisenmenger's syndrome. Drugs 2008; 68: 1049-66. https://doi.org/10.2165/00003495-200868080-00004
  10. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: Guidelines from the american heart association: A guideline from the american heart association rheumatic fever, endocarditis and kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. J Am Dent Assoc 2007; 138: 739-45, 47-60.
  11. Lumley J, Whitwam JG, Morgan M. General anesthesia in the presence of eisenmenger's syndrome. Anesth Analg 1977; 56: 543-7.
  12. Manley MC, Skelly AM, Hamilton AG. Dental treatment for people with challenging behaviour: General anaesthesia or sedation? Br Dent J 2000; 188: 358-60. https://doi.org/10.1038/sj.bdj.4800480
  13. Schwilden H, Schuttler J. Target controlled anaesthetic drug dosing. Handb Exp Pharmacol 2008; 425-50.
  14. Lee BS, Shin TJ, Kim HJ, Choi YJ, Lee SE, Chang JH, et al. Effect site concentrations of propofol for dental treatment under deep sedation in intellectually disabled patients. J Korean Dent Soc Anesthesiol 2014; 14: 167-72. https://doi.org/10.17245/jkdsa.2014.14.3.167
  15. Kiyama S, Yoshikawa T. Target-controlled infusion of propofol for the difficult airway. Anaesth Intensive Care 1998; 26: 591-2.
  16. Sung JH, Kim HJ, Choi YJ, Lee SE, Seo KS. Comparison of efficacy of propofol when used with or without remifentanil during conscious sedation with a targetcontrolled infuser for impacted teeth extraction. J Korean Dent Soc Anesthesiol 2014; 14: 213-9.

피인용 문헌

  1. Application of sevoflurane inhalation sedation in dental treatment: a mini review vol.21, pp.4, 2016, https://doi.org/10.17245/jdapm.2021.21.4.321